Nuveen Asset Management, LLC Eloxx Pharmaceuticals, Inc. Transaction History

Nuveen Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$1.35 - $3.36 $153,193 - $381,282	-113,477 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.02 - $4.54 $12,623 - $18,977	4,180 Added 3.82%	113,477 $377,000
Q4 2020 Feb 16, 2021	BUY	$2.42 - $4.48 $3,668 - $6,791	1,516 Added 1.41%	109,297 $435,000
Q3 2020 Nov 16, 2020	SELL	$2.53 - $3.4 $23,797 - $31,980	-9,406 Reduced 8.03%	107,781 $283,000
Q2 2020 Aug 14, 2020	BUY	$1.56 - $3.65 $166 - $390	107 Added 0.09%	117,187 $355,000
Q1 2020 May 14, 2020	BUY	$1.96 - $7.96 $41,234 - $167,462	21,038 Added 21.9%	117,080 $229,000
Q4 2019 Feb 14, 2020	SELL	$3.19 - $7.56 $71,468 - $169,374	-22,404 Reduced 18.91%	96,042 $707,000
Q3 2019 Nov 14, 2019	BUY	$4.37 - $9.91 $116,469 - $264,121	26,652 Added 29.03%	118,446 $535,000
Q2 2019 Aug 15, 2019	BUY	$8.77 - $12.49 $805,033 - $1.15 Million	91,794 New	91,794 $916,000

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.